Susquehanna International Group’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,768
Closed -$1.98K 13581
2023
Q1
$1.98K Sell
13,768
-1,513
-10% -$242 ﹤0.01% 12376
2022
Q4
$1.83K Sell
15,281
-19,144
-56% -$2.76K ﹤0.01% 12139
2022
Q3
$6K Sell
34,425
-133,720
-80% -$72K ﹤0.01% 12872
2022
Q2
$298K Sell
168,145
-516,136
-75% -$1.16M ﹤0.01% 9583
2022
Q1
$2.06M Sell
684,281
-255,302
-27% -$683K ﹤0.01% 5407
2021
Q4
$3.5M Buy
939,583
+501,378
+114% +$2.93M ﹤0.01% 4379
2021
Q3
$2.6M Buy
438,205
+35,485
+9% +$498K ﹤0.01% 5265
2021
Q2
$7M Buy
402,720
+65,194
+19% +$1.19M ﹤0.01% 3429
2021
Q1
$6.45M Buy
337,526
+208,601
+162% +$3.81M ﹤0.01% 3460
2020
Q4
$2.26M Buy
+128,925
New +$1.54M ﹤0.01% 4838

Other funds holding HGEN

Susquehanna International Group's HGEN Position: Q2 2023 in Review

Susquehanna International Group sold out of HUMANIGEN, INC. (HGEN) in Q2 2023, closing a stake of 13,768 shares — an estimated $1.98K sold.

Susquehanna International Group first reported a position in HGEN in Q4 2020 and held it in 10 quarters. The position peaked at $7M in Q2 2021. 38 funds tracked by Wall St. Rank hold HGEN as of Q2 2023.

  • Susquehanna International Group reported no remaining HUMANIGEN, INC. position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 13,768 HUMANIGEN, INC. shares in Q2 2023, an estimated $1.98K.
  • Susquehanna International Group first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 10 quarters.
  • Susquehanna International Group's HUMANIGEN, INC. position peaked at $7M in Q2 2021.
  • 38 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.